single500MG
NAD +
500MG Protocol
NAD + 500MG
Injection Freq.
Inject once daily
Cycle Sched.
Daily subcutaneous injections for 8–16 weeks with gradual dose titration
Reconstitution
3.0 mL BAC water
Supports cellular energy production and mitochondrial function (NAD+ pool replenishment)
Case reports/pilot studies suggest cognitive and metabolic-support signals at moderate daily ranges
High-dose IV protocols described in open-label settings for addiction support
No severe adverse events reported in published NAD+/NADH trials described on page
1
Reconstitution Requirements
- 3.0 mL BAC water
| Step | Week Range | Dose | Units |
|---|---|---|---|
| 1 | Weeks 1–1 | 50 mg | 30 |
| 2 | Weeks 2–2 | 75 mg | 45 |
| 3 | Weeks 3–8 | 100 mg | 60 |
| 4 | Weeks 9–12 | 100 mg | 60 |
| 5 | Weeks 13–16 | 100 mg | 60 |
Inject once daily
Daily subcutaneous injections for 8–16 weeks with gradual dose titration
The NAD+ 500 mg / 10 mL protocol describes the same core biology as other NAD+ pages, with emphasis on practical maintenance dosing. NAD+ is presented as essential for redox reactions and energy production (glycolysis, TCA cycle, oxidative phosphorylation) and as a substrate for cellular maintenance pathways such as DNA repair and mitochondrial biogenesis. The page explains that NAD+ levels decline with age and metabolic stress, which may contribute to mitochondrial dysfunction and reduced cellular resilience. While much clinical research has used high-dose intravenous NAD+ infusions for acute applications (including addiction-support protocols), the protocol emphasizes that subcutaneous or intramuscular injections at lower doses are being explored as practical maintenance approaches. The page’s rationale is convenience and consistent self-administration with gradual titration to minimize side effects. Overall, the mechanism narrative is that restoring NAD+ pools may support energy and repair capacity, while tolerability depends strongly on dosing speed and total exposure.
Insomnia, anxiety, or fatigue if escalated too quickly
Mild injection-site reactions (redness/itching/soreness)
Transient headache or flushing (dose-dependent)
Higher daily doses may require supervision due to metabolite accumulation concerns
- Use aseptic technique: wipe vial stopper with alcohol; use new sterile syringe/needle
- Add diluent slowly down the vial wall to minimize foaming
- Gently swirl/roll until fully dissolved (do not shake)
- Label vial with reconstitution date and concentration; protect from light
- Refrigerate after reconstitution (commonly 2–8 °C) unless protocol states otherwise
- Avoid repeated freeze–thaw cycles
- Bacteriostatic Water for Injection contains benzyl alcohol preservative (multi-dose); follow protocol for beyond-use (many peptide protocols use ~28 days after mixing)
- Avoid benzyl-alcohol-containing diluents in neonates/infants (safety warning for benzyl alcohol)